학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 184건 | 목록 1~20
Academic Journal
Foy P; Division of Hematology and Oncology Medical College of Wisconsin Milwaukee Wisconsin USA.; Higa S; Agios Pharmaceuticals, Inc. Cambridge Massachusetts USA.; Zhao J; Agios Pharmaceuticals, Inc. Cambridge Massachusetts USA.; Keapoletswe K; IQVIA Limited London UK.; Cirneanu L; IQVIA Limited London UK.; Venerus A; IQVIA Solutions Italy Srl Milan Italy.; Raiteri L; IQVIA Limited London UK.; Landfeldt E; IQVIA Stockholm Sweden.; Iob E; IQVIA Limited London UK.; Institute of Epidemiology and Healthcare University College London London UK.; Lombard L; Agios Pharmaceuticals, Inc. Cambridge Massachusetts USA.; Li J; Agios Pharmaceuticals, Inc. Cambridge Massachusetts USA.; Zagadailov E; Agios Pharmaceuticals, Inc. Cambridge Massachusetts USA.
Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101761942 Publication Model: eCollection Cited Medium: Internet ISSN: 2688-6146 (Electronic) Linking ISSN: 26886146 NLM ISO Abbreviation: EJHaem Subsets: PubMed not MEDLINE
Academic Journal
Zagadailov E; Formerly of Agios Pharmaceuticals, Inc., Cambridge, MA, USA.; Al-Samkari H; Division of Hematology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Boscoe AN; Agios Pharmaceuticals, Inc., Cambridge, MA, USA.; McGee B; Agios Pharmaceuticals, Inc., Cambridge, MA, USA.; Shi S; Analysis Group, Inc., Montreal, Canada.; Macaulay D; Formerly Analysis Group, Inc., New York, NY, USA.; Shi L; School of Public Health & Tropical Medicine, Tulane University, New Orleans, LA, USA.; Garcia-Horton V; Analysis Group, Inc., New York, NY, USA.
Publisher: Taylor & Francis Country of Publication: England NLM ID: 9708388 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1607-8454 (Electronic) Linking ISSN: 10245332 NLM ISO Abbreviation: Hematology Subsets: MEDLINE
Academic Journal
Musallam KM; Thalassemia Center, Burjeel Medical City, Abu Dhabi, United Arab Emirates.; Lombard L; Agios Pharmaceuticals, Cambridge, Massachusetts, USA.; Kistler KD; Xcenda LLC, Carrollton, Texas, USA.; Arregui M; Xcenda LLC, Carrollton, Texas, USA.; Gilroy KS; Agios Pharmaceuticals, Cambridge, Massachusetts, USA.; Chamberlain C; Agios Pharmaceuticals, Cambridge, Massachusetts, USA.; Zagadailov E; Agios Pharmaceuticals, Cambridge, Massachusetts, USA.; Ruiz K; Xcenda LLC, Carrollton, Texas, USA.; Taher AT; Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE
Report
Kuo KHM; Division of Hematology, University of Toronto, Toronto, Ontario, Canada.; Grace RF; Dana-Farber/Boston Children's Cancer and Blood Disorder Center, Harvard Medical School, Boston, Massachusetts, USA.; van Beers EJ; Center for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Barcellini W; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Glenthøj A; Department of Haematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Holzhauer S; Department of Pediatric Hematology and Oncology, Charité University Medicine, Berlin, Germany.; Beynon V; Agios Pharmaceuticals, Inc., Cambridge, Massachusetts, USA.; Morris S; Agios Pharmaceuticals, Inc., Cambridge, Massachusetts, USA.; Li J; Agios Pharmaceuticals, Inc., Cambridge, Massachusetts, USA.; Zagadailov E; Agios Pharmaceuticals, Inc., Cambridge, Massachusetts, USA.; Patel P; Agios Pharmaceuticals, Inc., Cambridge, Massachusetts, USA.; Al-Samkari H; Division of Hematology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE
Academic Journal
Van Gorp T; Leuven Cancer Institute, University Hospitals Leuven and KU Leuven, Leuven, Belgium; Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven, Belgium.; Moore KN; Department of Gynecologic Oncology, OU Health Stephenson Cancer Center, Oklahoma City, OK, USA; Gynecologic Oncology Group Partners (GOG-P), Philadelphia, PA, USA.; Konecny GE; Gynecologic Oncology Group Partners (GOG-P), Philadelphia, PA, USA; UCLA Health Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA.; Leary A; Department of Medical Oncology, Gustave Roussy, Villejuif, France; Groupe d'Investigateurs National des Etudes des Cancers Ovariens et du Sein (GINECO), Paris, France.; García-García Y; Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT), Universitat Autònoma de Barcelona, Sabadell, Spain; Grupo Español de Investigación en Cáncer Ginecológico (GEICO), Madrid Spain.; Banerjee S; Gynaecology Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, UK; National Cancer Research Institute (NCRI), London, UK.; Lorusso D; Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Humanitas San Pio X, Milan, Italy; Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO) Group, Seoul, South Korea.; Lee JY; Yonsei Cancer Center and Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.; Moroney JW; Gynecologic Oncology Group Partners (GOG-P), Philadelphia, PA, USA; Department of Obstetrics and Gynecology, The University of Chicago, Chicago, IL, USA.; Caruso G; Department of Gynecology, European Institute of Oncology (IEO) IRCCS, Milan, Italy; Mario Negri Gynecologic Oncology group (MaNGO), Milan, Italy.; Klasa-Mazurkiewicz D; Division of Gynecology and Obstetrics, Department of Gynecology, Obstetrics and Neonatology, Medical University of Gdańsk, Gdańsk, Poland; Polish Gynecologic Oncology Group (PGOG), Warsaw, Poland.; Tromp J; Department of Medical Oncology, Amsterdam University Medical Center, Amsterdam, The Netherlands; Dutch Gynaecological Oncology Group (DGOG), Amsterdam, The Netherlands.; Martin LP; Gynecologic Oncology Group Partners (GOG-P), Philadelphia, PA, USA; Division of Hematology/Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Breuer S; Helmsley Cancer Center, Shaare Zedek Medical Center, Jerusalem, Israel.; Leath CA 3rd; Gynecologic Oncology Group Partners (GOG-P), Philadelphia, PA, USA; O'Neal Comprehensive Cancer Center, The University of Alabama at Birmingham, Birmingham, AL, USA.; Cibula D; Department of Gynaecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University, Czech Republic; General University Hospital in Prague, Prague, Czech Republic; Central and Eastern European Gynecologic Oncology Group (CEEGOG), Prague, Czech Republic.; Weroha SJ; Gynecologic Oncology Group Partners (GOG-P), Philadelphia, PA, USA; Department of Oncology, Mayo Clinic, Rochester, MN, USA.; Estévez-García P; Grupo Español de Investigación en Cáncer Ginecológico (GEICO), Madrid Spain; Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío, Universidad de Sevilla, Consejo Superior de Investigaciones Científicas, Seville, Spain; Medical Oncology Department, Hospital Universitario Virgen del Rocío, Seville, Spain; CIBER de CANCER, Institute of Health Carlos III, Madrid, Spain.; O'Malley DM; Gynecologic Oncology Group Partners (GOG-P), Philadelphia, PA, USA; The James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.; Miller RE; National Cancer Research Institute (NCRI), London, UK; Department of Medical Oncology, Barts Health NHS Trust, London, UK; Department of Medical Oncology, University College London Hospital, London, UK.; Coffman L; Gynecologic Oncology Group Partners (GOG-P), Philadelphia, PA, USA; UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Scandurra G; Gynecologic Oncology Group Partners (GOG-P), Philadelphia, PA, USA; Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO) Group, Seoul, South Korea; Medical Oncology Unit, Azienda Ospedaliera Cannizzaro, Catania, Italy; Kore University of Enna, Enna, Italy.; Berton D; Groupe d'Investigateurs National des Etudes des Cancers Ovariens et du Sein (GINECO), Paris, France; Medical Oncology, Institut de Cancérologie de l'Ouest, Centre René Gauducheau, Saint-Herblain, France.; Li L; ImmunoGen, Waltham, MA, USA.; Zagadailov E; ImmunoGen, Waltham, MA, USA.; Diver EJ; ImmunoGen, Waltham, MA, USA.; Trédan O; Groupe d'Investigateurs National des Etudes des Cancers Ovariens et du Sein (GINECO), Paris, France; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.; Hilpert F; Jerusalem Hospital, Hamburg, Germany; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) study group, Wiesbaden, Germany. Electronic address: hilpert@mammazentrum.eu.
Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Zagadailov, E
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어